Daniel Birnbaum

发表

Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma.

D. Le Paslier, D. Paslier, D. Birnbaum, 1995, Oncogene.

P. Viens, C. Ginestier, J. Jacquemier, 2003 .

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy

F. Bertucci, S. Granjeaud, B. Esterni, 2006, Oncogene.

Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias

D. Birnbaum, L. Xerri, V. Trouplin, 2010, Leukemia.

Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma.

D. Birnbaum, J. Grosgeorge, C. Theillet, 1997, Cytogenetics and cell genetics.

Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.

D. Birnbaum, G. Monges, J. Adélaı̈de, 1995, British Journal of Cancer.

Alterations of NFIA in chronic malignant myeloid diseases

D. Birnbaum, V. Trouplin, W. Vainchenker, 2009, Leukemia.

Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth

D. Birnbaum, G. Fournier, D. Isnardon, 2011, Oncogene.

Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies

F. Bertucci, D. Birnbaum, P. Finetti, 2010, Leukemia.

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia

D. Birnbaum, C. Arnoulet, N. Vey, 2015, Blood Cancer Journal.

Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique

D. Birnbaum, F. Speleman, G. Flandrin, 2008, Leukemia.

HLA cosmid clones show complete, widely spaced human class I genes with occasional clusters.

D. Birnbaum, M. Malissen, B. Jordan, 1982, Gene.

Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes

F. Bertucci, D. Birnbaum, V. Trouplin, 2007, Leukemia.

The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene.

D. Birnbaum, O. Casasnovas, M. Pébusque, 2000, British journal of haematology.

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

D. Birnbaum, P. Bonnier, E. Charafe-Jauffret, 2007, British Journal of Cancer.

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.

D. Birnbaum, F. Penault-Llorca, C. Theillet, 1994, British Journal of Cancer.

Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact.

D. Birnbaum, H. Sobol, E. Charafe-Jauffret, 2001, International journal of oncology.

Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.

D. Birnbaum, J. Peyrat, D. Stoppa-Lyonnet, 1996, Cancer research.

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes

D. Birnbaum, N. Cervera, N. Vey, 2011, Blood cancer journal.

Mutations in ASXL 1 are associated with poor prognosis across the spectrum of malignant myeloid diseases

V. Gelsi-Boyer, M. Brecqueville, A. Murati, 2012 .